Taro Hirai

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Skeletal Muscle

Cardiovascular Risk Factors

Epidermal Growth Factor Receptor

Top Venues

Journal of diabetes investigation

Journal of clinical medicine

Kanazawa Medical University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Kanazawa Medical University Apr 01 2016

Japan

Dr :: Diabetology & Endocrinology

Publications

Keiji Shimada, Keizo Kanasaki, Makoto Kato, Yoshio Ogura, Yuta Takagaki, Itaru Monno, Taro Hirai, Munehiro Kitada, Daisuke Koya
Adenosine/adenosine type 1 receptor signaling pathway did not play dominant roles on the influence of sodium-glucose cotransporter 2 inhibitor in the kidney of bovine serum albumin-overloaded streptozotocin-induced diabetic mice. Journal of diabetes investigation 13 (6) (2022)
Jing Xu, Taro Hirai, Daisuke Koya, Munehiro Kitada
Effects of SGLT2 Inhibitors on Atherosclerosis: Lessons from Cardiovascular Clinical Outcomes in Type 2 Diabetic Patients and Basic Researches. Journal of clinical medicine 11 (1) (2021)
Taro Hirai, Munehiro Kitada, Itaru Monno, Erina Oda, Yoshihiro Hayashi, Keiji Shimada, Yuta Takagaki, Yoshio Ogura, Mizue Fujii, Kazunori Konishi, Masaru Sakurai, Atsushi Nakagawa, Daisuke Koya
Sodium-glucose cotransporter 2 inhibitors in type 2 diabetes patients with renal function impairment slow the annual renal function decline, in a real clinical practice. Journal of diabetes investigation 12 (9) (2021)
Taro Hirai, Munehiro Kitada, Yoshihiro Hayashi, Itaru Monno, Yuta Takagaki, Keiji Shimada, Yoshio Ogura, Mizue Fujii, Kazunori Konishi, Atsushi Nakagawa, Daisuke Koya
Case report of superior mesenteric artery syndrome that developed in a lean type 2 diabetes patient and was associated with rapid body weight loss after sodium-glucose cotransporter 2 inhibitor administration. Journal of diabetes investigation 11 (5) (2020)